Legal & General Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.4K | Buy |
9,175
+1,543
| +20% | +$5.13K | ﹤0.01% | 2933 |
|
|
2026
Q1 | $27.3K | Sell |
7,632
-256
| -3% | -$1.02K | ﹤0.01% | 2862 |
|
|
2025
Q4 | $27.7K | Hold |
7,888
| – | – | ﹤0.01% | 2905 |
|
|
2025
Q3 | $25.7K | Sell |
7,888
-63,578
| -89% | -$200K | ﹤0.01% | 2941 |
|
|
2025
Q2 | $175K | Sell |
71,466
-51,161
| -42% | -$259K | ﹤0.01% | 2596 |
|
|
2025
Q1 | $818K | Buy |
122,627
+47,173
| +63% | +$466K | ﹤0.01% | 2247 |
|
|
2024
Q4 | $948K | Buy |
75,454
+8,267
| +12% | +$124K | ﹤0.01% | 2262 |
|
|
2024
Q3 | $1.24M | Buy |
67,187
+130
| +0.2% | +$2.66K | ﹤0.01% | 2159 |
|
|
2024
Q2 | $1.44M | Buy |
67,057
+860
| +1% | +$19.8K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $1.78M | Sell |
66,197
-243
| -0.4% | -$6.9K | ﹤0.01% | 1987 |
|
|
2023
Q4 | $1.99M | Buy |
66,440
+9,283
| +16% | +$205K | ﹤0.01% | 1958 |
|
|
2023
Q3 | $1.17M | Buy |
57,157
+2,719
| +5% | +$49.4K | ﹤0.01% | 2132 |
|
|
2023
Q2 | $1.08M | Buy |
54,438
+605
| +1% | +$12.2K | ﹤0.01% | 2193 |
|
|
2023
Q1 | $922K | Buy |
53,833
+13,041
| +32% | +$255K | ﹤0.01% | 2170 |
|
|
2022
Q4 | $798K | Buy |
40,792
+5,217
| +15% | +$96.1K | ﹤0.01% | 2213 |
|
|
2022
Q3 | $568K | Sell |
35,575
-3,398
| -9% | -$53K | ﹤0.01% | 2313 |
|
|
2022
Q2 | $536K | Buy |
38,973
+9,274
| +31% | +$111K | ﹤0.01% | 2320 |
|
|
2022
Q1 | $471K | Sell |
29,699
-69
| -0.2% | -$1.19K | ﹤0.01% | 2409 |
|
|
2021
Q4 | $650K | Buy |
29,768
+87
| +0.3% | +$2.37K | ﹤0.01% | 2338 |
|
|
2021
Q3 | $887K | Buy |
29,681
+7,566
| +34% | +$275K | ﹤0.01% | 2273 |
|
|
2021
Q2 | $980K | Buy |
22,115
+373
| +2% | +$16.2K | ﹤0.01% | 2217 |
|
|
2021
Q1 | $965K | Buy |
21,742
+16,700
| +331% | +$917K | ﹤0.01% | 2203 |
|
|
2020
Q4 | $277K | Buy |
5,042
+198
| +4% | +$7.22K | ﹤0.01% | 2363 |
|
|
2020
Q3 | $111K | Sell |
4,844
-1,509
| -24% | -$37.2K | ﹤0.01% | 2459 |
|
|
2020
Q2 | $133K | Buy |
6,353
+546
| +9% | +$9.84K | ﹤0.01% | 2453 |
|
|
2020
Q1 | $81K | Sell |
5,807
-1,125
| -16% | -$22.3K | ﹤0.01% | 2468 |
|
|
2019
Q4 | $158K | Buy |
6,932
+1,241
| +22% | +$20.7K | ﹤0.01% | 2457 |
|
|
2019
Q3 | $67K | Hold |
5,691
| – | – | ﹤0.01% | 2648 |
|
|
2019
Q2 | $85K | Buy |
5,691
+914
| +19% | +$15.9K | ﹤0.01% | 2585 |
|
|
2019
Q1 | $84K | Buy |
4,777
+873
| +22% | +$13.8K | ﹤0.01% | 2543 |
|
|
2018
Q4 | $58K | Buy |
3,904
+739
| +23% | +$12.3K | ﹤0.01% | 2637 |
|
|
2018
Q3 | $78K | Hold |
3,165
| – | – | ﹤0.01% | 2579 |
|
|
2018
Q2 | $62K | Buy |
+3,165
| New | +$59.9K | ﹤0.01% | 2658 |
|
|
2017
Q2 | – | Sell |
-494
| Closed | -$4K | – | 3373 |
|
|
2017
Q1 | $4K | Hold |
494
| – | – | ﹤0.01% | 3248 |
|
|
2016
Q4 | $12K | Buy |
+494
| New | +$14.1K | ﹤0.01% | 3197 |
|
Other funds holding RCKT
RI
NM
MC
Legal & General Group's RCKT Position: Q2 2026 in Review
Legal & General Group increased its Rocket Pharmaceuticals (RCKT) stake by 20% in Q2 2026, buying an estimated $5.13K and bringing the position to 9,175 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2933.
Legal & General Group first reported a position in RCKT in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.99M in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.
- Legal & General Group held 9,175 shares of Rocket Pharmaceuticals worth $31.4K as of Q2 2026.
- Legal & General Group bought 1,543 Rocket Pharmaceuticals shares in Q2 2026, an estimated $5.13K.
- Rocket Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2933 holding.
- Legal & General Group first reported a position in Rocket Pharmaceuticals in Q4 2016 and has held it in 35 quarters since.
- Legal & General Group's Rocket Pharmaceuticals position peaked at $1.99M in Q4 2023.
- 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.